BDBM734184 3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxyphenyl octylcarbamate::US20250129027, Example 160

SMILES CCCCCCCCNC(=O)Oc3cc(O)cc(c2cncc(c1nnco1)c2)c3

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 734184   

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734184(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734184(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 5.50E+3nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent